Shares of Charles River Laboratories International have moved -2.7% today, and are now trading at a price of $203.79. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 282,942 compared to the stock's average volume of 520,222.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Based in Wilmington, United States the company has 20,000 full time employees and a market cap of $10,430,563,328.
The company is now trading -17.19% away from its average analyst target price of $246.08 per share. The 12 analysts following the stock have set target prices ranging from $205.0 to $280.0, and on average give Charles River Laboratories International a rating of buy.
The stock's 52 week high is $262.0 per share and its 52 week low is $181.22. Based on Charles River Laboratories International's average net margin growth of 6.2% over the last 4 years, its core business remains strong and the stock price may recover in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-12-31 | 3,976,060 | 486,226 | 12.23 | 10.78 |
| 2021-12-31 | 3,540,160 | 390,982 | 11.04 | -11.4 |
| 2020-12-31 | 2,923,933 | 364,304 | 12.46 | 29.66 |
| 2019-12-31 | 2,621,226 | 252,019 | 9.61 | n/a |
